Carregant...
Reprogramming therapeutics: iPS cell prospects for neurodegenerative disease
The recent description of somatic cell reprogramming to an embryonic stem (ES) cell-like phenotype, termed induced pluripotent stem (iPS) cell technology, presents an exciting potential venue towards cell-based therapeutics and disease models for neurodegenerative disorders Two recent studies from D...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2009
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3659427/ https://ncbi.nlm.nih.gov/pubmed/19217371 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuron.2009.01.024 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|